Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease

Rationale: Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in chronic obstructive pulmonary disease (COPD). The 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine (PCV7) induces a more...

Full description

Saved in:
Bibliographic Details
Main Authors: Dransfield, Mark T., Nahm, Moon H., Han, MeiLan K., Harnden, Sarah, Criner, Gerard J., Martinez, Fernando J., Scanlon, Paul D., Woodruff, Prescott G., Washko, George R., Connett, John E., Anthonisen, Nicholas R., Bailey, William C.
Format: Artigo
Language:Inglês
Published: American Thoracic Society 2009
Subjects:
B. Chronic Obstructive Pulmonary Disease
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2742743/
https://ncbi.nlm.nih.gov/pubmed/19556517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200903-0488OC
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items